These findings provide mechanistic insight into the potential use of Lf as a valuable therapeutic agent for the treatment of AD, on the one hand, being itself a promising brain-targeting ligand for the modification of cationic polymeric systems [41,42], facilitating drug delivery into the brain. This evidence concerns the gene LTF and Alzheimer disease.